home / stock / dbvt / dbvt news


DBVT News and Press, DBV Technologies S.A. From 04/20/20

Stock Information

Company Name: DBV Technologies S.A.
Stock Symbol: DBVT
Market: NASDAQ
Website: dbvtechnologies.com

Menu

DBVT DBVT Quote DBVT Short DBVT News DBVT Articles DBVT Message Board
Get DBVT Alerts

News, Short Squeeze, Breakout and More Instantly...

DBVT - DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting

Montrouge, France, April 20, 2020 DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting Shareholders approve all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage...

DBVT - Is Aimmune Therapeutics a Buy?

On March 16, Aimmune Therapeutics (NASDAQ: AIMT) announced that the first patients in the U.S. had begun treatment with its recently approved immunotherapy for peanut allergies, Palforzia. On the same day, investors learned that the U.S. Food and Drug Administration (FDA) had questions ...

DBVT - A Tale of 2 Biotechs With Competing Peanut Allergy Treatments

For parents, having a child with peanut allergies come into accidental contact with the protein, via unlabeled foods at a potluck event, birthday party, or school lunch can be devastating. The results range in severity, from minor skin reactions to life-threatening anaphylaxis. It's an...

DBVT - DBV Technologies: Don't Panic - The Good, The Bad, And The Opportunity

Introduction At the end of 2019 I wrote an article highlighting the reasons why I felt DBV Technologies (NASDAQ: DBVT ) was substantially undervalued. At the time DBVT was trading for around $9, subsequently climbed to $13.49 by mid-January, and then nosedived to a low of $2.02. The s...

DBVT - Ordinary and Extraordinary General Meeting of April 20, 2020 to be Held in Closed Virtual Session Due to COVID-19 Pandemic

Montrouge, France, April 10, 2020 Ordinary and Extraordinary General Meeting of April 20, 2020 to be Held in Closed Virtual Session Due to COVID-19 Pandemic DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical...

DBVT - Ordinary and Extraordinary General Meeting of April 20, 2020

Montrouge, France, March 30, 2020 Ordinary and Extraordinary General Meeting of April 20, 2020 Procedures for Obtaining Preparatory Documents for the General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage b...

DBVT - DBV Technologies Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F

Montrouge, France, March 20, 2020 DBV Technologies Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced the filing of its 2019 Universal Reg...

DBVT - RDS.A, NRZ among premarket gainers

Waitr Holdings (NASDAQ: WTRH ) +70%  as few consumer stocks are performing well during the rough road ahead. More news on: Waitr Holdings Inc., iFresh Inc., Biomerica, Inc., Stocks on the move, , Read more ...

DBVT - SLS, APRN among premarket gainers

Biomerica (NASDAQ: BMRA ) +133%  on advancement of rapid coronavirus test. More news on: Biomerica, Inc., IMV Inc., Vaxart, Inc., Stocks on the move, , Read more ...

DBVT - Monthly information regarding the total number of voting rights and  total number of shares of the Company as of February 29, 2020 and March 4, 2020

                      Monthly information regarding the total number of voting rights and  total number of shares of the Company as of February 29, 2020 and March 4, 2020 (Article 223-16 of the General Regulations of the ...

Previous 10 Next 10